A United Front for Better Pediatric Clinical Trials

In this ISSUE

Hope. The Power for the Rare Disease Journey

Are Clinical Trial Data Shared by the EMA Under Policy 0070 Really Public Data?

Oracle Pursues mHealth in Clinical Trials

Data Management

The Cloud Has Been Conquered, But the Dust is Still Settling

A multitude of data sources leaves clinical data management systems in catch-up mode–and researchers dizzy trying to follow the data–but there is hope for simplification on the horizon.
... /Read more/

Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
North America: Tuesday, November 13, 2018 at 11am EDT | 10am CDT | 8am PDT

Market Landscaping

How to Avoid Common Pitfalls of Market Landscaping

Key tips and resources to help evade the common traps of market landscaping–today an increasingly high-stakes and comprehensive task during clinical development.
... /Read more/

On the brink of change: How academic data and machine learning can revolutionize Alzheimer's drug development
On Demand

Learn More

Calendar

/ Women of Color in Pharma Second Annual Conference 11/2-11/3 /

/ 2018 HBA Annual Conference 11/5-11/6 /

/ Crossroads: An Artia Solutions Conference 11/7-11/9 /

/ Risk-Based Trial Management and Monitoring 2018 11/8-11/9 /

/ Clinical Trial Legal and Contracting Forum 12/4-12/5 /

/ Clinical Trial Financial Management Summit 12/5-12/6 /

Research Reveals Data Quality Issues Slow Clinical Trial Progression – What Can You Do To Prevent This?
On Demand

Learn More

Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
Europe: Thursday, November 8, 2018 at 3pm GMT | 4pm CET

Pediatric Trials

A United Front for Better Pediatric Clinical Trials

Forming strategic alliances and collaborating to optimize study design can significantly improve pediatric drug development.
... /Read more/

Neuropathic Pain Studies: Patient Selection, Study Design, and Clinical Trial Challenges
Tuesday, November 6, 2018 at 11am EST | 8am PST | 4pm GMT | 5pm CET

Antimicrobials

FDA Supports Streamlined Trials for New Antimicrobials

FDA is joining with other federal health agencies and the biomedical community to advance science, regulatory policies, and reimbursement strategies to combat the need for new medicines for infectious diseases.
... /Read more/

IDENTIFYING NASH PATIENTS: Solutions and Strategies
Thursday, November 1, 2018 at 11am EDT

Therapeutic Areas

Mid-Sized CROs Consolidate in Specialized Therapeutic Areas

Q&A highlights one such example of M&A movement in the CRO space toward mid-sized companies focused in specific disease indications.
... /Read more/

Artificial Intelligence: A Transformative Journey for Pharmacovigilance
On Demand

Learn More

Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Challenging the Status Quo: The Diffusion of Technology in Study Startup
On Demand

Learn More

Advertise

Todd Baker
Group Publisher
todd.baker@ubm.com

website / blog / advertise / subscribe